S&P/ASX 200 Index (ASX: XJO) stocks are 0.3% lower at 8,765 points on Friday.
Brokers have reduced their ratings on several ASX shares this week.
Let's review.
Image source: Getty Images
NextDC Ltd (ASX: NXT)
The NextDC share price is $5.48, down 4.8% today.
Over the past month, this ASX tech share has more than halved in value.
Morgan Stanley downgraded NextDC shares to a hold rating today.
The broker slashed its 12-month price target from $19 to $6.70.
This still suggests a potential 22% upside ahead.
Ampol Ltd (ASX: ALD)
The Ampol share price is $38.99, down 2.2% today.
Over the past month, this ASX energy stock has lost 12% of its valuation.
RBC Capital downgraded Ampol shares to a hold rating on Monday.
The broker trimmed its 12-month price target from $46.50 to $44.50.
This implies a potential 14% upside ahead.
Cleanaway Waste Management Ltd (ASX: CWY)
Cleanaway Waste Management shares are steady at $3 on Friday.
Morgans downgraded Cleanaway Waste Management shares from buy to hold.
The broker has a share price target of $3.10, suggesting 3% upside ahead.
Cleanaway has agreed to a takeover by EQT Infrastructure for $3.095 per share.
Regis Resources Ltd (ASX: RRL)
The Regis Resources Ltd share price is $6.07, down 4.9% today.
Over the past month, this ASX 200 gold mining stock has fallen 24%.
Morgans downgraded Regis Resources shares to a hold rating on Wednesday.
The broker has a 12-month price target of $6.46.
This implies a potential 4% upside ahead.
FleetPartners Group Ltd (ASX: FPR)
The FleetPartners share price is $5.12, down 0.4% today.
Over the past month, this ASX 200 financial stock has risen 10%.
Ord Minnett downgraded FleetPartners shares to a hold rating on Tuesday.
The broker has a target price of $5.30, which implies 3% upside ahead.
Clinuvel Pharmaceuticals Ltd (ASX: CUV)
Clinuvel Pharmaceuticals shares are $7.02, down 0.7% on Friday.
Over the past month, this ASX healthcare stock has fallen 15%.
Morgans downgraded Clinuvel shares to a hold call this week.
The broker slashed its 12-month price target from $10 to $7.
This implies a potential 1% downside ahead.
